Novel Therapies and Multidisciplinary Strategies in Metastatic Triple-Positive Breast Cancer
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Abstract
The management of metastatic hormone receptor–positive (HR+) and human epidermal growth factor receptor 2–positive (HER2+) breast cancer continues to evolve with the development of novel targeted therapies. At JADPRO Live, presenters discussed therapies for this subtype of breast cancer, adverse events, management strategies, as well as biomarkers to consider when making treatment decisions.
Fields of Study & Subjects
Advanced Breast Cancer Therapies
Breast Cancer Treatment Studies
HER2/EGFR in Cancer Research
Publication details
- Journal / source
- Journal of the Advanced Practitioner in Oncology
- Volume
- 17
- Issue
- 2
- Publication date
- 27 February 2026
- Language
- EN